Laporan Kasus : Pseudotrombositopenia pada Pasien Pre-Operasi
DOI:
https://doi.org/10.36452/jkdoktmeditek.v29i1.2550Keywords:
EDTA, hitung trombosit, trombositopeniaAbstract
Pseudotrombositopenia didefinisikan sebagai jumlah hitung trombosit rendah palsu yang terukur oleh faktor alat analisis hematologi. Diketahui EDTA-dependent pseudotrombositopenia merupakan salah satu penyebab trombositopenia dengan prevalensi 0,1-2%. Pseudotrombositopenia yang tidak terdiagnosis dapat menyebabkan kesalahan dalam keputusan klinis. Laporan kasus ini disusun agar dapat meningkatkan kewaspadaan dalam mendiagnosis pseudotrombositopenia. Laki-laki 56 tahun melakukan pemeriksaan pre-operasi dan didapatkan adanya trombositopenia dengan jumlah trombosit 16.000/uL tanpa ditemukan adanya kelainan pada parameter koagulasi lainnya dan tidak terdapat adanya perdarahan aktif, Pada pemeriksaan morfologi darah ditemukan banyak platelet clumping. Dokter menduga adanya EDTA-dependent pseudotrombositopenia lalu melakukan pengambilan sampel darah kembali satu hari kemudian dengan menggunakan antikoagulan natrium sitrat. Sampel darah tersebut diperiksa dengan mesin hematologi Sysmex XN-550 dan didapatkan jumlah trombosit yaitu 112.000/uL. Bila dijumpai kondisi jumlah trombosit rendah / trombositopenia tanpa ada tanda klinis pendarahan yang jelas, maka perlu dipertimbangkan adanya EDTA-dependent pseudothrombocytopenia. Pemeriksaan morfologi darah tepi dan pengulangan darah lengkap menggunakan sampel darah dengan antikoagulan lainnya, yaitu natrium sitrat menjadi salah satu metode dalam menegakkan adanya EDTA-dependent pseudothrombocytopenia.
References
Shabnam I. Ethylenediaminetetraacetic acid (EDTA) – dependent pseudothrombocytopenia: a case report. J Clin Diagn Res [Internet]. 2014 [cited 2022 Apr 5]; Available from: http://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2014&volume=8&issue=10&page=FL03&issn=0973-709x&id=5019
Deng J, Chen Y, Zhang S, Li L, Shi Q, Liu M, et al. Mindray SF-Cube technology: an effective way for correcting platelet count in individuals with EDTA dependent pseudo thrombocytopenia. Clin Chim Acta. 2020;502:99–101.
McKenzie S, Piwowar KL, Williams L. Clinical laboratory hematology. Fourth edition. Amerika. Pearson, 2020.p.775-85
World Health Organization. Educational modules on clinical use of blood [Internet]. Geneva: World Health Organization; 2021 [cited 2022 Apr 15]. Available from: https://apps.who.int/iris/handle/10665/350246
Mehta AB, Gomez K. Clinical haematology. 2nd ed. London. Taylor & Francis, 2018. p.80
Shaikh A, Rizwan D, Talpur RA, Jiskani SA. Ethylenediaminetetraacetic acid (EDTA) -induced pseudothrombocytopenia -a routine challenge. 2020. [cited 2022 Apr 15]. Available from: https://www.researchgate.net/publication/350457594_Ethylenediaminetetraacetic_Acid_EDTA_-Induced_Pseudothrombocytopenia_-A_Routine_Challenge
Schuff-Werner P, Mansour J, Gropp A. Pseudo-thrombocytopenia (PTCP). A challenge in the daily laboratory routine? J Lab Med. 2020;44(5):295–304.
Kharel H, Pokhrel NB, Pant SR, Shrestha S, Agrawal B. Surgical delay due to ethylenediaminetetraacetic acid-induced pseudothrombocytopenia. Cureus [Internet]. 2020 Jul 19 [cited 2022 Apr 19];12(7). Available from: https://www.cureus.com/articles/35806-surgical-delay-due-to-ethylenediaminetetraacetic-acid-induced-pseudothrombocytopenia
Bahri R, Aznag MA, Khayati S, Elfarssani F, Eddyb S, Yahyaoui H, et al. Pseudothrombocytopenia: automate-blood smear confrontation. Int J Recent Innov Med Clin Res. 2021;3(1):21–9.
Lippi G, Plebani M. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med [Internet]. 2012 Jan 1 [cited 2022 Apr 15];50(8). Available from: https://www.degruyter.com/document/doi/10.1515/cclm-2012-0081/html
Kohli R, Chaturvedi S. Epidemiology and clinical manifestations of immune thrombocytopenia. Hämostaseologie. 2019;39(03):238–49.
Konkle B. Disorder of platelets and vessel wall. In: Longo D, Fauci A, Kasper D. Harrison’s principles of internal medicine. 20th ed. New York: McGraw Hill Medical; 2018. p.824
Tosetto A, Castaman G. How i treat type 2 variant forms of von Willebrand disease. Blood. 2015;125(6):907–14.
Tan GC, Stalling M, Dennis G, Nunez M, Kahwash SB. Pseudothrombocytopenia due to platelet clumping: a case report and brief review of the literature. Case Rep Hematol. 2016;2016:e3036476.
Lardinois B, Favresse J, Chatelain B, Lippi G, Mullier F. Pseudothrombocytopenia—a review on causes, occurrence and clinical implications. J Clin Med. 2021;10(4):594.
Bhar VS, Singh R. Platelet satellitism: unusual cause of spurious thrombocytopenia. J Hematop. 2019;12(3):171–2.
Fang CH, Chien YL, Yang LM, Lu WJ, Lin MF. EDTA-dependent pseudothrombocytopenia. Formos J Surg. 2015;48(3):107–9.
Kovacs F, Varga M, Pataki Z, Rigo E. Pseudothrombocytopenia with multiple anticoagulant sample collection tubes. Interv Med Appl Sci. 2016 ;8(4):181–3.
Scavone M, Bossi E, Podda GM, Cattaneo M. MgSO4 anticoagulant prevents pseudothrombocytopenia by preserving the integrity of the platelet GPIIb-IIIa complex. Br J Haematol. 2021;192(6):e144–8.
Prates RF, Viana RC, Oliveira MV, Souza CL. Pseudothrombocytopenia: incidence and strategy for resolution in clinical laboratory. J Bras Patol E Med Lab. 2017;53:382–7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jullyanny Waty Wijaya, Monica Adisuhanto, Gregorio Gavriel Singgih
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.